Makary vows FDA will uphold ‘gold standard of trusted science’ during senate hearing

Key takeaways:Lawmakers grilled Martin Makary, MD, MPH, on transparency, his plans for mifepristone and his stance on the recently cancelled Vaccine Advisory Committee meeting during Thursday’s senate hearing to be the next FDA commissioner.Makary, a surgeon and public policy researcher at Johns Hopkins University, has been nominated to be the agency’s next leader under the administration of President Donald J. Trump. During the hearing, he told members of the U.S. Senate Committee on Health, Education, Labor and Pensions that he is a scientist who values good data and commonRead More